A longitudinal study on cortisol, prolactin and thyroid hormones in users of norplantR subdermal implants or a copper T device

S. Díaz, M. Pavez, A. Brandeis, H. Cárdenas, H. B. Croxatto

Resultado de la investigación: Article

8 Citas (Scopus)

Resumen

A longitudinal study was undertaken to assess PRL, cortisol, TSH, T3 and T4 levels in NORPLANT4 implant users (n = 22) and Copper T users (n = 20). Participants were healthy women with no contraindication for hormonal contraception. Samples were drawn at 0930 to 1000 h twice pretreatment and at month 2, 4, 6, 12, 24 and 36 after insertion. At the second treatment month, a second sample was obtained at 1600 h to assess cortisol diurnal variation. Hormones were measured by RIA. Values for all hormones were similar in NORPLANTR and Copper T users. No significant changes occurred throughout the study period. Elevated PRL levels (>500 mU/1) were found in three women from each group before and during treatment but no clinical evidence of hyperprolactinemia was detected. The results of this study reassure that long-term use of NORPLANTR implants do not impair plasma levels of cortisol, prolactin and thyroid hormones.

Idioma originalEnglish
Páginas (desde-hasta)505-517
Número de páginas13
PublicaciónContraception
Volumen40
N.º4
DOI
EstadoPublished - 1 ene 1989

Huella dactilar

Thyroid Hormones
Prolactin
Longitudinal Studies
Hydrocortisone
Copper
Equipment and Supplies
Hormones
Hyperprolactinemia
Contraception
Healthy Volunteers
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Citar esto

@article{2a9bf419d9664e3bac8c913b3ae3feba,
title = "A longitudinal study on cortisol, prolactin and thyroid hormones in users of norplantR subdermal implants or a copper T device",
abstract = "A longitudinal study was undertaken to assess PRL, cortisol, TSH, T3 and T4 levels in NORPLANT4 implant users (n = 22) and Copper T users (n = 20). Participants were healthy women with no contraindication for hormonal contraception. Samples were drawn at 0930 to 1000 h twice pretreatment and at month 2, 4, 6, 12, 24 and 36 after insertion. At the second treatment month, a second sample was obtained at 1600 h to assess cortisol diurnal variation. Hormones were measured by RIA. Values for all hormones were similar in NORPLANTR and Copper T users. No significant changes occurred throughout the study period. Elevated PRL levels (>500 mU/1) were found in three women from each group before and during treatment but no clinical evidence of hyperprolactinemia was detected. The results of this study reassure that long-term use of NORPLANTR implants do not impair plasma levels of cortisol, prolactin and thyroid hormones.",
author = "S. D{\'i}az and M. Pavez and A. Brandeis and H. C{\'a}rdenas and Croxatto, {H. B.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0010-7824(89)90056-5",
language = "English",
volume = "40",
pages = "505--517",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "4",

}

A longitudinal study on cortisol, prolactin and thyroid hormones in users of norplantR subdermal implants or a copper T device. / Díaz, S.; Pavez, M.; Brandeis, A.; Cárdenas, H.; Croxatto, H. B.

En: Contraception, Vol. 40, N.º 4, 01.01.1989, p. 505-517.

Resultado de la investigación: Article

TY - JOUR

T1 - A longitudinal study on cortisol, prolactin and thyroid hormones in users of norplantR subdermal implants or a copper T device

AU - Díaz, S.

AU - Pavez, M.

AU - Brandeis, A.

AU - Cárdenas, H.

AU - Croxatto, H. B.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A longitudinal study was undertaken to assess PRL, cortisol, TSH, T3 and T4 levels in NORPLANT4 implant users (n = 22) and Copper T users (n = 20). Participants were healthy women with no contraindication for hormonal contraception. Samples were drawn at 0930 to 1000 h twice pretreatment and at month 2, 4, 6, 12, 24 and 36 after insertion. At the second treatment month, a second sample was obtained at 1600 h to assess cortisol diurnal variation. Hormones were measured by RIA. Values for all hormones were similar in NORPLANTR and Copper T users. No significant changes occurred throughout the study period. Elevated PRL levels (>500 mU/1) were found in three women from each group before and during treatment but no clinical evidence of hyperprolactinemia was detected. The results of this study reassure that long-term use of NORPLANTR implants do not impair plasma levels of cortisol, prolactin and thyroid hormones.

AB - A longitudinal study was undertaken to assess PRL, cortisol, TSH, T3 and T4 levels in NORPLANT4 implant users (n = 22) and Copper T users (n = 20). Participants were healthy women with no contraindication for hormonal contraception. Samples were drawn at 0930 to 1000 h twice pretreatment and at month 2, 4, 6, 12, 24 and 36 after insertion. At the second treatment month, a second sample was obtained at 1600 h to assess cortisol diurnal variation. Hormones were measured by RIA. Values for all hormones were similar in NORPLANTR and Copper T users. No significant changes occurred throughout the study period. Elevated PRL levels (>500 mU/1) were found in three women from each group before and during treatment but no clinical evidence of hyperprolactinemia was detected. The results of this study reassure that long-term use of NORPLANTR implants do not impair plasma levels of cortisol, prolactin and thyroid hormones.

UR - http://www.scopus.com/inward/record.url?scp=0024446374&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(89)90056-5

DO - 10.1016/0010-7824(89)90056-5

M3 - Article

VL - 40

SP - 505

EP - 517

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 4

ER -